Market topic · 2026-10-06
Primary Markets Group September 2026 U.S. IPO Update
The U.S. IPO market experienced a modest decline in deal count in September but a slight increase in proceeds with six offerings raising $1.9 billion in aggregate proceeds compared to $1.8 billion raised across seven deals in August. Looking at pricing performance, the strongest first-day return came from Adarx Pharmac
Market response
See tape and rates board for confirmation; treat headline as a catalyst until price confirms.
Why it matters
Second-order: map to Fed path, oil/inflation, AI hardware, or credit/breadth before sizing risk.
IPO
From the AlphaShot daily brief · 2026-10-06.